Inicio › Cáncer de riñón (carcinoma de células renales) › Misuri

Ensayos clínicos de Cáncer de riñón (carcinoma de células renales) en Misuri

23 estudios sobre Cáncer de riñón (carcinoma de células renales) buscan participantes en Misuri.

Ciudades en Misuri

Texto oficial del estudio (inglés)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Washington University Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
y 21 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Washington University in St. Louis, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Saint Francis Medical Center, Cape Girardeau
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Siteman Cancer Center at West County Hospital, Creve Coeur
y 11 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07594106

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Washington University, St Louis

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Washington University School of Medicine ( Site 0114), St Louis

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07489495

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Washington University School of Medicine, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07293351

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Washington University School of Medicine, St Louis

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06863311

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05267626

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Saint Francis Medical Center, Cape Girardeau
MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
Mercy Hospital Springfield, Springfield
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Siteman Cancer Center - St. Peters, City of Saint Peters
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - North County, Florissant
y 4 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Saint Francis Medical Center, Cape Girardeau
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
y 10 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07115043

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06966024

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06910657

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Saint Francis Medical Center, Cape Girardeau
Parkland Health Center - Farmington, Farmington
Sainte Genevieve County Memorial Hospital, Sainte Genevieve
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT07383441

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jun 2026 · NCT06026410

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Siteman Cancer Center, Washington University, St Louis

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 may 2026 · NCT05363280

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Washington University Medical Campus, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 dic 2025 · NCT05856981

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT06682793

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
y 19 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2025 · NCT04510597

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.